We suspect new Covid strain, samples sent to NCDC: Maharashtra Health Min

Maharashtra Health Minister Rajesh Tope on Wednesday hinted at the possibility of new strains of Covid-19 in the state as "some patients are showing behaviours other than routine ones."

coronavirus, India
coronavirus test kits
ANI General News
1 min read Last Updated : Apr 07 2021 | 2:47 PM IST

Maharashtra Health Minister Rajesh Tope on Wednesday hinted at the possibility of new strains of COVID-19 in the state as "some patients are showing behaviours other than routine ones."

"New Strains are suspected because we are seeing other behaviours in COVID-19 patients than routine behaviours. Patients are also showing non-routine behaviours after the infection," Tope said.

"National Institute of Virology (NIV) is doing genomic sequencing of our samples. It is sending its report to National Centre for Disease Control (NCDC). Now, NCDC will guide us about if any new protocol is to be followed for the treatment," he added.

Informing that as the state, currently, is consuming 50,000 doses of COVID-19 drug Remdesivir on a daily basis, Maharashtra needs a higher number of doses.

The price of Remdesivir will be capped between Rs 1100-1400 per dose.

Tope was addressing a press conference over the COVID-19 situation in the state on Wednesday.

Earlier, he said that the state is facing a vaccine shortage and has requested 40 lakh doses every week from the Centre.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMaharashtraHealth crisisCoronavirus Vaccine

First Published: Apr 07 2021 | 2:33 PM IST

Next Story